Vazyme Biotech

Molecular Research and Diagnostics

Since the establishment in 2012, Vazyme Biotech has been dedicated to their mission "Science and Technology Make a Healthier Life" to focus on technology innovation and continuously expand the application fields of core technologies in life science. Currently, they have a portfolio of over 200 kinds of genetic engineering recombinases, more than 1,000 kinds of high-performance antigens, monoclonal antibodies and other key raw materials, in addition to over 600 finished products. As a R&D based company, they have been holding theirselves to the highest standards of ethics, accountability and professionalism. Their global research and development operations make sure to provide quality products, solutions, and services locally to customers, and more importantly, to do as much as it can to meet the unmet customers’ needs. For now, Vazyme Biotech is present in more than 60 countries and regions worldwide to get close to local customers.